STAT5A and invasive carcinoma: This is in line with recent findings showing that breast lesions with aberrantly proliferating cells like atypical ductal hyperplasia, ductal carcinoma in situ and invasive carcinomas are characterized by a reduction or absence of STAT5a expression [42].